U.S. Animal Model Market Research, 2017-2021 & 2022-2032 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. Animal Model Market Outlook to 2032” report has been added to ResearchAndMarkets.com’s offering.

This report on the animal model market offers a U.S. industry analysis for 2017-2021 and an opportunity assessment for 2022-2032.

The report consists of a comprehensive assessment of the most important market dynamics. On conducting thorough research on the historical as well as current growth parameters of the animal model market, growth prospects of the market are obtained with maximum precision.

The report features unique and salient factors that may make a huge impact on the development of the animal model market during the forecast period. It can help market players modify their manufacturing and marketing strategies to envisage maximum growth in this market in the coming years.

The report provides detailed information about the current and future growth prospects of the animal model market in the most comprehensive way for a better understanding of readers.

Key Topics Covered:

1. Executive Summary

1.1. U.S. Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage/Taxonomy

2.2. Market Definition/Scope/Limitations

2.3. Inclusion & Exclusion

3. Key Market Trends

3.1.1. Key Trends Impacting The Market

3.1.2. Innovation/Development Trends

4. Market Background

4.1. Macro-Economic Factors

4.1.1. U.S. GDP Growth Outlook

4.1.2. U.S. Healthcare Expenditure Outlook

4.1.3. U.S. Pharmaceutical Industry Outlook

4.2. Forecast Factors – Relevance & Impact

4.2.1. Increasing Intent of Academic & Research Institutions

4.2.2. Increasing Number of Vaccine Testing and Development

4.2.3. Disease Prevalence and Growth

4.2.4. Rising Focus on Technological Advancements in Biotechnology

4.2.5. Increased Funding and Support from Government

4.2.6. Adoption Rate

4.2.7. Increasing Number of Clinical Trials

4.2.8. Increasing Preference for Customized Animal Models

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunity Analysis

5. Key Success Factors

5.1. Application Vs Animal Model Intensity Mapping

5.2. Key Strategies by Manufacturers

5.3. PESTLE Analysis

5.4. Porters Analysis

5.5. Key Regulations

5.6. Supply Chain Analysis

5.7. Cost Structure

5.8. Type of Animal Model and Analysis thereof

5.9. Animal Model in Disease Research

5.10. Animal Model for Clinical Research

5.11. List of animal model suppliers in the U.S.

5.11.1. Small Animals

5.11.2. Large Animals

5.12. Animal model outlook in Boston

5.12.1. Market Size by Animal in Boston, 2021

5.12.2. Demand Trends

5.12.2.1. Small Animals

5.12.2.2. Large Animals

5.12.3. Animal Model Lab Layout

6. COVID19 Crisis Analysis

6.1. Current COVID19 Statistics and Probable Future Impact

6.2. Current GDP Projection and Probable Impact

6.3. Current Economic Projection as compared to 2008 Economic analysis

6.4. COVID19 and Impact Analysis

6.4.1. By Species

6.4.2. By Therapeutic Area

6.4.3. By Application

6.4.4. By End User

6.4.5. By Country

7. U.S. Animal Model Market Demand (US$ Million) Analysis 2017-2021 and Forecast, 2022-2032

7.1. Historical Market Value (US$ Million) Analysis, 2017-2021

7.2. Current and Future Market Value (US$ Million) Projections, 2022-2032

7.2.1.1. Y-o-Y Growth Trend Analysis

7.2.1.2. Absolute $ Opportunity Analysis

8. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by Species Introduction/Key Findings

8.1. Introduction/Key Findings

8.2. Historical Market Size (US$ Million) Analysis by Species, 2017-2021

8.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Species, 2022-2032

8.3.1. Rats

8.3.2. Mice

8.3.3. Pig

8.3.4. Rabbits

8.3.5. Monkeys

8.3.6. Dogs

8.3.7. Cats

8.3.8. Other Species

8.4. Market Attractiveness Analysis by Species

9. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by Application

9.1. Introduction/Key Findings

9.2. Historical Market Size (US$ Million) Analysis by Application, 2017-2021

9.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Application, 2022-2032

9.3.1. Drug Discovery/Development

9.3.2. Basic and Applied Research

9.4. Market Attractiveness Analysis by Application

10. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by Therapeutic Area

10.1. Introduction/Key Findings

10.2. Historical Market Size (US$ Million) Analysis by Therapeutic Area, 2017-2021

10.3. Current and Future Market Size (US$ Million) Analysis and Forecast by Therapeutic Area, 2022-2032

10.3.1. Metabolic Disease

10.3.2. Cardiovascular Disease

10.3.3. Neurologic Disease

10.3.4. Oncology

10.4. Market Attractiveness Analysis by Therapeutic Area

11. U.S. Animal Model Market Analysis 2017-2021 and Forecast 2022-2032, by End User

11.1. Introduction/Key Findings

11.2. Historical Market Size (US$ Million) Analysis by End User, 2017-2021

11.3. Current and Future Market Size (US$ Million) Analysis and Forecast by End User, 2022-2032

11.3.1. Academic & Research Institutions

11.3.2. Pharmaceutical Companies

11.3.3. Biotechnology Companies

11.3.4. Contract Research Organizations (CROs)

11.3.5. Other End Users

11.4. Market Attractiveness Analysis by End User

12. Market Structure Analysis

12.1. Market Analysis by Tier of Companies

12.2. Market Concentration

12.3. Market Share Analysis of Top Players

13. Competition Analysis

• Charles River Laboratories
• The Jackson Laboratory
• Taconic Biosciences, Inc.
• Genoway
• Envigo (Inotiv, Inc.)
• Marshall BioResources
• Janvier Labs
• Applied stem cells
• Biocytogen
• Transposagen Biopharmaceuticals, Inc. (Hera Bio Labs)
• Cyagen
• Ingenious targeting labs
• Crown Bioscience Inc. (JSR Corporation)
• Harbour Biomed
• Sinclair Bio Resources
• Alpha Genesis Inc.
• Creative Animodel
• DaVinci Biomedical Research Products, Inc

For more information about this report visit https://www.researchandmarkets.com/r/3f0kpo

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900